Tofacitinib-induced progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome

Neurol Sci. 2023 Oct;44(10):3737-3739. doi: 10.1007/s10072-023-06897-4. Epub 2023 Jun 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immune Reconstitution Inflammatory Syndrome* / drug therapy
  • Leukoencephalopathy, Progressive Multifocal* / chemically induced
  • Piperidines / adverse effects
  • Pyrimidines / adverse effects

Substances

  • tofacitinib
  • Piperidines
  • Pyrimidines